Видео ютуба по тегу Daniel Catenacci

Paramount Ice Welcomes Daniel Catenacci | Partner & Co-Head of Hockey Development #icehockey
Paramount Ice Welcomes Daniel Catenacci | Partner & Co-Head of Hockey Development #icehockey
EIHL: Late Game Winners
EIHL: Late Game Winners
Daniel Catenacci scores the overtime winner! Guildford Flames Vs Amiens Gothiques 1/9/24
Daniel Catenacci scores the overtime winner! Guildford Flames Vs Amiens Gothiques 1/9/24
Guildford Flames Sign Daniel Catenacci
Guildford Flames Sign Daniel Catenacci
Top 5 Plays from Day 5: Italy | 2024 #MensWorlds 1A
Top 5 Plays from Day 5: Italy | 2024 #MensWorlds 1A
Top 5 Plays: Italy | 2024 #MensWorlds Division 1A
Top 5 Plays: Italy | 2024 #MensWorlds Division 1A
Highlights | Romania vs. Italy | 2024 #MensWorlds Division 1A
Highlights | Romania vs. Italy | 2024 #MensWorlds Division 1A
1 Introduction Dr Dan's GEC Video Library
1 Introduction Dr Dan's GEC Video Library
Molecular Testing in Unresectable Biliary Tract Cancer | Daniel Catenacci, MD | ASCO22 GI Updates
Molecular Testing in Unresectable Biliary Tract Cancer | Daniel Catenacci, MD | ASCO22 GI Updates
GEJ Adenocarcinoma Treatment Based on ESOPEC Study | Daniel Catenacci, MD | ASCO22 GI Cancer Updates
GEJ Adenocarcinoma Treatment Based on ESOPEC Study | Daniel Catenacci, MD | ASCO22 GI Cancer Updates
Fanatics представляет фанчаты с Каапо Какко
Fanatics представляет фанчаты с Каапо Какко
ASCO GI 2021: trial updates
ASCO GI 2021: trial updates
MAHOGANY: margetuximab in gastric cancer
MAHOGANY: margetuximab in gastric cancer
Welcome back Dan Catenacci #7, Domenic Alberga #88 & Justin Fazio #32!
Welcome back Dan Catenacci #7, Domenic Alberga #88 & Justin Fazio #32!
Updates from the MAHOGANY study in gastric cancer
Updates from the MAHOGANY study in gastric cancer
Perioperative genotype-dosed FOLFIRINOX with margin-negative resection in gastroesophageal cancer
Perioperative genotype-dosed FOLFIRINOX with margin-negative resection in gastroesophageal cancer
Dr. Catenacci on the Challenges of Developing Novel Therapies in Gastroesophageal Cancer
Dr. Catenacci on the Challenges of Developing Novel Therapies in Gastroesophageal Cancer
Daniel Catenacci, MD, on the role of margetuximab to improve treatment outcomes of GI cancers
Daniel Catenacci, MD, on the role of margetuximab to improve treatment outcomes of GI cancers
Daniel Catenacci, MD, shares opinion on the role of checkpoint inhibitors for GI malignancies
Daniel Catenacci, MD, shares opinion on the role of checkpoint inhibitors for GI malignancies
Daniel Catenacci, MD, discusses margetuximab in the treatment of esophageal and gastric cancer
Daniel Catenacci, MD, discusses margetuximab in the treatment of esophageal and gastric cancer
Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020
Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020
Dr. Catenacci on Treatment Selection in Esophagogastric Junction Adenocarcinoma
Dr. Catenacci on Treatment Selection in Esophagogastric Junction Adenocarcinoma
Daniel Catenacci, MD | Advances in Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis
Daniel Catenacci, MD | Advances in Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis
Daniel Catenacci, MD | Advice on Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis
Daniel Catenacci, MD | Advice on Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis
Daniel Catenacci, MD | Key Point of Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis
Daniel Catenacci, MD | Key Point of Gastrointestinal Cancer at 2019 ASCO Direct Highlights St. Louis